Table 5 Maintenance therapy in patients with EoE that achieved histologic remission with PPI monotherapy and FED monotherapy
Survey responses | Patients with histologic remission of EoE on PPI monotherapy and FED monotherapy (n = 9) |
|---|---|
Question: What treatment plan do you primarily follow? | |
 PPI monotherapy | 1 (11.11%) |
 FED monotherapy | 5 (55.56%) |
 FED monotherapy with PPI on as needed basis | 3 (33.33%) |
Question: Why are you following this treatment plan? | |
 Current treatment plan is sustainable | 6 (66.67%) |
 Perceived symptom benefits of current treatment plan | 3 (33.33%) |
Question: Do you believe that this process has increased your overall quality of life with your EoE and helped you to identify a treatment plan that aligned with your lifestyle and beliefs? | |
 Strongly agree | 5 (55.56%) |
 Agree | 2 (22.22%) |
 Neutral | 2 (22.22%) |
 Disagree | 0 (0%) |
 Strongly disagree | 0 (0%) |